biomarker 4,101 words KG: neurodegenerative disease
Contents

Cerebrospinal Fluid (CSF) Biomarkers Overview

🔬 Protein Info
Gene SymbolNEURODEGENERATIVE DISEASE
[Tau Protein](/proteins/tau-protein)p-tau181, p-tau217, p-tau231
[Beta-Amyloid](/proteins/beta-amyloid)Aβ42/Aβ40 ratio
[TREM2](/proteins/trem2)Soluble TREM2 in CSF
DiagnosisSupporting clinical diagnosis of neurodegenerative diseases
ProgressionMonitoring disease progression
Clinical TrialsEnriching patient selection and measuring treatment response
KG Connections243 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (26)

TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE-TREM2 Interaction Modulation
Score: 0.74
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
Retinal Vascular Microcirculation Rescue
Score: 0.72
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Noradrenergic-Tau Propagation Blockade
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.71
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70
pg 1/2Next →

Related Analyses (24)

Extracellular vesicle biomarkers for early AD detection
neurodegeneration · archived
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived

Related Experiments (22)

Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40
Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40
Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40

Knowledge Graph (12 edges)

CGG repeat expansions causes neurodegenerative disease
PPAR-γ treats neurodegenerative disease
ESRRA regulates neurodegenerative disease
ESRRG regulates neurodegenerative disease
PPAR implicated_in neurodegenerative disease
RELN implicated_in neurodegenerative disease
APOE implicated_in neurodegenerative disease
HCN4 implicated_in neurodegenerative disease
HCN2 implicated_in neurodegenerative disease
HCN1 implicated_in neurodegenerative disease

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.